$GTII
GLOBAL TECH INDUSTRIES GROUP, INC. Stock $gtii

$gtii Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017198 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$7.404M	$55.77M	$732.0K
YoY Change	1117.0%	7518.93%	1.09%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$267.00	$268.00	$890.00
YoY Change	-0.37%	-69.89%	229.63%
% of Gross Profit
Operating Expenses	$7.405M	$72.63M	$1.143M
YoY Change	654.67%	6254.91%	57.79%
Operating Profit	-$7.405M	-$72.63M	-$1.143M
YoY Change	654.67%	6254.91%	57.79%
Interest Expense	$14.00K	$14.02K	-$85.53K
YoY Change	13.91%	-116.39%	-276.17%
% of Operating Profit
Other Income/Expense, Net	-$26.00K	$39.99K	-$85.53K
YoY Change	-811.91%	-146.75%
Pretax Income	-$7.431M	-$72.59M	-$1.228M
YoY Change	660.15%	5809.22%	81.78%
Income Tax
% Of Pretax Income
Net Earnings	-$7.431M	-$72.59M	-$1.228M
YoY Change	660.15%	5809.22%	81.78%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02	-$0.25	$0.00
Diluted Earnings Per Share	-$0.02	-$0.25	-$4.801K
COMMON SHARES
Basic Shares Outstanding	345.3M shares	303.9M shares	255.9M shares
Diluted Shares Outstanding	334.2M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.040M	$4.307M	$485.8K
YoY Change	788.5%	786.53%	211.86%
Cash & Equivalents	$4.012M	$4.267M	$349.8K
Short-Term Investments	$28.00K	$40.00K	$136.0K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables			$0.00
Other Receivables			$0.00
Total Short-Term Assets	$4.040M	$4.307M	$485.8K
YoY Change	788.5%	786.53%	28.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$267.00	$536.00	$980.00
YoY Change	-80.06%	-45.31%	-63.43%
Goodwill
YoY Change
Intangibles	$14.99M	$14.99M
YoY Change	16.27%
Long-Term Investments
YoY Change
Other Assets	$14.99M	$14.99M	$0.00
YoY Change	15.67%
Total Long-Term Assets	$14.99M	$14.99M	$72.16K
YoY Change	15.66%	20674.41%	2592.54%
TOTAL ASSETS
Total Short-Term Assets	$4.040M	$4.307M	$485.8K
Total Long-Term Assets	$14.99M	$14.99M	$72.16K
Total Assets	$19.03M	$19.30M	$558.0K
YoY Change	41.85%	3358.5%	46.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.766M	$2.680M	$1.712M
YoY Change	48.81%	56.5%	109.03%
Accrued Expenses	$437.5K	$426.8K	$441.3K
YoY Change	9.72%	-3.28%	24.34%
Deferred Revenue
YoY Change
Short-Term Debt	$1.306M	$971.1K	$1.843M
YoY Change	49.94%	-47.31%	80.5%
Long-Term Debt Due	$180.0K	$180.0K	$0.00
YoY Change	42.31%
Total Short-Term Liabilities	$5.765M	$5.333M	$3.997M
YoY Change	77.1%	33.43%	69.62%
LONG-TERM LIABILITIES
Long-Term Debt	$4.788M	$4.788M	$0.00
YoY Change	-1.11%
Other Long-Term Liabilities	$0.00		$0.00
YoY Change
Total Long-Term Liabilities	$4.788M	$4.788M
YoY Change	-1.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.765M	$5.333M	$3.997M
Total Long-Term Liabilities	$4.788M	$4.788M
Total Liabilities	$10.55M	$10.12M	$3.997M
YoY Change	30.33%	153.24%	69.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$327.7M	-$320.3M
YoY Change	38.67%
Common Stock	$345.5K	$310.3K
YoY Change	34.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.477M	$9.177M	-$3.439M
YoY Change
Total Liabilities & Shareholders Equity	$19.03M	$19.30M	$558.0K
YoY Change	41.85%	3358.5%	46.6%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$7.431M	-$72.59M	-$1.228M
YoY Change	660.15%	5809.22%	81.78%
Depreciation, Depletion And Amortization	$267.00	$268.00	$890.00
YoY Change	-0.37%	-69.89%	229.63%
Cash From Operating Activities	-$590.4K	-$198.2K	$35.12K
YoY Change	-1116.65%	-664.45%	-148.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$50.00K	-$183.9K
YoY Change	-100.0%	-127.18%
Cash From Investing Activities	$0.00	$50.00K	-$183.9K
YoY Change	-100.0%	-127.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	335.0K	$1.095M	139.5K
YoY Change	-515.58%	685.0%	9.99%
NET CHANGE
Cash From Operating Activities	-590.4K	-$198.2K	35.12K
Cash From Investing Activities	0.000	$50.00K	-183.9K
Cash From Financing Activities	335.0K	$1.095M	139.5K
Net Change In Cash	-255.4K	$946.8K	-9.320K
YoY Change	-5387.16%	-10258.44%
FREE CASH FLOW
Cash From Operating Activities	-$590.4K	-$198.2K	$35.12K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000356590
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition		usd
CY2023Q1	GTII	Payments To Acquire Gti Acquisition PaymentsToAcquireGTIAcquisition		usd
CY2022Q1	GTII	Payments To Acquire Gti Acquisition PaymentsToAcquireGTIAcquisition		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2022Q1	GTII	Proceeds From Share Holder Advance ProceedsFromShareHolderAdvance		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Notes Payable Related And Nonrelated Party Status Extensible Enumeration NotesPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Notes Payable Related And Nonrelated Party Status Extensible Enumeration NotesPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q4	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	GTII	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q4	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeited Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedIntrinsicValue		usd
CY2022Q4	us-gaap	Assets Assets	18347244	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	960742	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	952507	usd
CY2023Q1	GTII	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	1718905	usd
CY2022Q4	GTII	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	1551208	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	426813	usd
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.75
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	GTII	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	GTII	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeited Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedIntrinsicValue		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-10210
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	GLOBAL TECH INDUSTRIES GROUP, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1604380
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	511 Sixth Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10011
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	204 7926
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	345296829	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4266931	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3320164	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	40000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	36000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4306931	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3356164	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	536	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	803	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	536	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	803	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14990277	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14990277	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14990277	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14990277	usd
CY2023Q1	us-gaap	Assets Assets	19297742	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	416774	usd
CY2023Q1	GTII	Notes Payable In Default NotesPayableInDefault	871082	usd
CY2022Q4	GTII	Notes Payable In Default NotesPayableInDefault	871082	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1075000	usd
CY2023Q1	GTII	Note Payable Current NotePayableCurrent	100000	usd
CY2022Q4	GTII	Note Payable Current NotePayableCurrent	80000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	180000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	180000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5332542	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4051571	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	4788177	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4788177	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4788177	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4788177	usd
CY2023Q1	us-gaap	Liabilities Liabilities	10120719	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8839748	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	310269968	shares
CY2023Q1	GTII	Common Stock Shares Held In Escrow CommonStockSharesHeldInEscrow	10000000	shares
CY2022Q4	GTII	Common Stock Shares Held In Escrow CommonStockSharesHeldInEscrow	10000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	262251320	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	252251320	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	252251320	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	310269	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	262251	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	329184669	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	256976102	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320317916	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-247730858	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177023	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9507496	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19297742	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18347244	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	103286	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	55216	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	55663487	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	676736	usd
CY2023Q1	GTII	Charitable Donations CharitableDonations	16860000	usd
CY2022Q1	GTII	Charitable Donations CharitableDonations	410000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	269	usd
CY2022Q1	us-gaap	Depreciation Depreciation	893	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	72627042	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1142845	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-72627042	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1142845	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	4000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-27000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	50000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	14015	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	58527	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39985	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-85527	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72587058	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1228372	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-72587058	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1228372	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	295433699	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255862345	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3874590	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	453108	usd
CY2022Q1	GTII	Stock Issued During Period Value Common Stock Issued For Charitable Donations StockIssuedDuringPeriodValueCommonStockIssuedForCharitableDonations	410000	usd
CY2022Q1	GTII	Adjustments To Additional Paid In Capital Stock Issued Revesal Of Acquisition AdjustmentsToAdditionalPaidInCapitalStockIssuedRevesalOfAcquisition	-6951245	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3360	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1228372	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3438559	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9507496	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9507496	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	55393225	usd
CY2023Q1	GTII	Stock Issued During Period Value Common Stock Issued For Charitable Donations StockIssuedDuringPeriodValueCommonStockIssuedForCharitableDonations	16860000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3360	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-72587058	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177023	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177023	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-72587058	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1228372	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	268	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	893	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	72253224	usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	863108	usd
CY2023Q1	GTII	Imputed Interest On Loan ImputedInterestOnLoan	3360	usd
CY2022Q1	GTII	Imputed Interest On Loan ImputedInterestOnLoan	3360	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	50000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	4000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-27000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8236	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	176038	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	167697	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	138013	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10039	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	55081	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-198234	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35121	usd
CY2022Q1	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	183933	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	50000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	50000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-183933	usd
CY2023Q1	GTII	Proceeds From Share Holder Advance ProceedsFromShareHolderAdvance	1075000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	20000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	50000	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	250470	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	339956	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1095001	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	139486	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	946767	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9324	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3320164	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	359143	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4266931	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	349818	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zO4MenLYx6xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B) <span id="xdx_86D_zAzYAqqYFLl3">USE OF MANAGEMENT’S ESTIMATES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Cash Cash	4266931	usd
CY2022Q4	us-gaap	Cash Cash	3320164	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-72587058	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1228372	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	295433699	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255862345	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2373	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	4000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-27000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	269	usd
CY2022Q1	us-gaap	Depreciation Depreciation	893	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	3214	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3214	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3214	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2678	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2411	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	536	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	803	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	14990277	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	6388	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt	4968177	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	10018085	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1581419	usd
CY2023Q1	GTII	Long Term Debt Maturities Repayments Of Principal After Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearThree	1070147	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	4968177	usd
CY2023Q1	GTII	Imputed Interest On Loan ImputedInterestOnLoan	3360	usd
CY2022Q1	GTII	Imputed Interest On Loan ImputedInterestOnLoan	3360	usd
CY2023Q1	GTII	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	1718905	usd
CY2022Q4	GTII	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	1551208	usd
CY2023Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	60059	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	48059	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	871082	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	871082	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	12199	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	12199	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	426813	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	416774	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	1899	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	399	usd
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	12199	usd
CY2022Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	12199	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	50000	usd
CY2022Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P12M
CY2022Q4	us-gaap	Notes Payable NotesPayable	30000	usd
CY2022Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P12M
CY2023Q1	us-gaap	Notes Payable NotesPayable	20000	usd
CY2023Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P12M
CY2023Q1	us-gaap	Loans Payable LoansPayable	4968177	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	180000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	815496	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1194638	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	23364803	shares
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	57689800	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	23361723	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.75
CY2021	GTII	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P1Y3M
CY2021Q4	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	57681330	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	1187331	shares
CY2022	GTII	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	2.75
CY2022Q4	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedIntrinsicValue	3265160	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	23361723	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.75
CY2022	GTII	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P0Y3M
CY2022Q4	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	54416170	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	23361723	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.75
CY2023Q1	GTII	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P0Y14D
CY2023Q1	GTII	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	54416170	usd
CY2021Q3	GTII	Stock Issued During Period Shares Relief And Relinguishment StockIssuedDuringPeriodSharesReliefAndRelinguishment	150000	shares
CY2021Q3	GTII	Stock Issued During Period Shares Restrictive Legends StockIssuedDuringPeriodSharesRestrictiveLegends	6000000	shares

Files In Submission

Name	View Source	Status
0001493152-23-017198-index-headers.html	Edgar Link	pending
0001493152-23-017198-index.html	Edgar Link	pending
0001493152-23-017198.txt	Edgar Link	pending
0001493152-23-017198-xbrl.zip	Edgar Link	pending
ex22-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gtii-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gtii-20230331_cal.xml	Edgar Link	unprocessable
gtii-20230331_def.xml	Edgar Link	unprocessable
gtii-20230331_lab.xml	Edgar Link	unprocessable
gtii-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTII
GLOBAL TECH INDUSTRIES GROUP, INC. Stock $gtii

2023 Q2 Form 10-Q Financial Statement

#000149315223017198 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTII GLOBAL TECH INDUSTRIES GROUP, INC. Stock $gtii

2023 Q2 Form 10-Q Financial Statement

#000149315223017198 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTII
GLOBAL TECH INDUSTRIES GROUP, INC. Stock $gtii